US 12365729
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
granted A61KA61K2039/505A61P
Quick answer
US patent 12365729 (Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis) held by Disc Medicine, Inc. expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Disc Medicine, Inc.
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00, A61P7/06